NEW YORK (GenomeWeb) – Oxford BioDynamics announced today that it has formed a strategic alliance with Shanghai-based private equity firm GL Capital Group to help it establish a footprint in China.

Under the terms of the deal, GL Capital will lead Oxford BioDynamics' business development activities in mainland China. In the role, GL Capital will identify, screen, and recommend potential partners for Oxford BioDynamics' epigenetic biomarkers and technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.